picrorhiza kurroa

Condiciones de salud que picrorhiza kurroa puede ayudar a apoyar.

• HipocondríaCientífico

  Multiple peer-reviewed studies demonstrate that P. kurroa extracts and isolated compounds (luteolin-5-O-glucopyranoside, picein) exhibit significant free-radical scavenging activity in DPPH, ABTS, and FRAP assays. Picroliv also reduces oxidative stress markers in animal disease models.

• EdemaCientífico

  P. kurroa has been investigated in several human clinical trials for bronchial asthma since the 1970s, with mixed but present evidence of benefit. Multiple RCTs and quasi-experimental trials exist; a Cochrane-referenced systematic review found one QED reported positive results. The compound androsin mechanistically prevents PAF-induced bronchial obstruction.

• Fatiga SuprarrenalCientífico

  Multiple preclinical studies demonstrate P. kurroa extracts lower blood glucose in diabetic rodent models via α-glucosidase inhibition, increased GLUT-4 translocation, and enhanced insulin secretion. Traditional Himalayan tribes have long used the root for prediabetes. No rigorous human RCTs exist yet, so evidence remains preclinical/in vitro.

• AlcalosisCientífico

  Several early Indian clinical trials and controlled animal studies support P. kurroa's role in bronchial conditions. The compound androsin inhibits platelet-activating factor (PAF)-induced bronchial obstruction. One placebo-controlled RCT (Doshi et al., 1983) showed mixed results, and a Cochrane-referenced systematic review rated the evidence as weak but present.

• Válvula IleocecalCientífico

  A pilot clinical study in dyslipidemia patients showed P. kurroa significantly reduced total cholesterol (max 25.36%) and LDL-C (max 28.79%) over 106 days. Preclinical NAFLD studies also show hepatic and serum cholesterol reduction. Evidence is preliminary-clinical in quality.

• ApendicitisCientífico

  P. kurroa extracts inhibit NF-κB signaling, suppress pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), and reduce carrageenan-induced edema and granuloma formation in rodent models. This mechanistic evidence is well-documented in peer-reviewed preclinical studies, though clinical trials in chronic inflammatory diseases are lacking.

• Sangrado (interno)Científico

  P. kurroa rhizome extracts have demonstrated significant antipyretic activity in rodent models at doses of 260–520 mg/kg. Ayurvedic and Tibetan traditions list it prominently as an antipyretic for 'chronic reoccurring fevers.' The preclinical evidence supports the traditional use, though human RCTs are absent.

• Síndrome de DownCientífico

  Picroliv from P. kurroa exhibits anti-allergic and anti-anaphylactic activity, inhibiting mast cell activation and PAF-mediated reactions in preclinical studies. Its immunomodulatory activity modulates both humoral and cell-mediated immune pathways relevant to food-allergic responses.

• Envenenamiento QuímicoCientífico

  Picrorhiza kurroa (Kutki) is a Himalayan herb with extensive use in Ayurvedic medicine for liver diseases, jaundice, and hepatitis. Its active constituent kutkin (picrosides I and II) demonstrates hepatoprotective effects including activation of FXR to regulate bile acid balance, antioxidant activity, and anti-cholestatic properties. Both traditional clinical use and preclinical evidence support liver detox applications.

• Dolor de cabeza (en racimos)Científico

  P. kurroa has been tested as an adjunct in vitiligo (a related autoimmune skin condition), with one self-controlled trial in 30 patients showing repigmentation when combined with phototherapy. Its immunomodulatory and anti-inflammatory properties are proposed to benefit psoriasis, though direct psoriasis RCTs are absent.

• Tos (seca)Científico

  Picroliv (the standardized iridoid glycoside fraction of P. kurroa) has demonstrated anti-allergic and anti-anaphylactic activity in animal models, inhibiting passive cutaneous anaphylaxis. Traditional Ayurvedic use for 'allergy' is well-documented. The NDNR notes clinical use for hayfever based on immunomodulatory properties.

• DebilidadCientífico

  A pilot clinical study (PMC, 2022) and a preclinical NAFLD model both show P. kurroa reduces elevated serum triglycerides. The clinical pilot treating dyslipidemia patients with 500 mg Kutaki tablets twice daily for 60–106 days showed up to 52% maximum reduction in serum triglycerides.

• Hernia HiatalCientífico

  A PMC-indexed mechanistic rodent study demonstrated P. kurroa methanol extract healed indomethacin-induced gastric ulcers by 45% (p<0.01) and restored mucosal prostaglandin E2 and EGF levels. Traditional use for gastric complaints is extensively documented.

• SofocosCientífico

  Picrorhiza kurroa (kutki) is an Ayurvedic herb studied as an adjunct in vitiligo photochemotherapy. A PubMed-indexed 1989 study demonstrated that P. kurroa leaf extract stimulates cell-mediated and humoral immune responses and may potentiate photochemotherapy in vitiligo. Authoritative natural medicine references (EBSCO Research Starters; Practical Dermatology 2025) list it as a proposed natural treatment for the condition.

• ArtritisTradicional

  P. kurroa rhizomes have been used in Ayurvedic and folk medicine for chronic constipation due to insufficient digestive secretion for thousands of years. It is classified as a laxative and digestive stimulant in traditional texts. No human clinical trials specifically for constipation have been published.

• Trastornos AutoinmunesTradicional

  P. kurroa is documented in Ayurvedic, Tibetan, and Chinese traditional medicine for the treatment of diarrhea and dysentery. This use is consistent across multiple ethnopharmacological sources. There are no human clinical trials specifically evaluating it for this indication.

• Ojos Inyectados en SangreTradicional

  Picrorhiza kurroa (kutki) is a key Ayurvedic hepatobiliary herb listed in the Ayurvedic Pharmacopoeia of India for liver and biliary disorders. Its picroside iridoid glycosides have documented choleretic and hepatoprotective activity in preclinical studies. Traditional use for jaundice, cholecystitis, and biliary dysfunction is well established.

• InfecciónTradicional

  Picrorhiza kurroa is used in Ayurvedic medicine as a powerful hepatobiliary tonic and cholagogue (Kutki/Katuka). It contains iridoid glycosides (picrosides I and II) that stimulate bile secretion and have hepatoprotective effects. It appears in traditional Ayurvedic pharmacopoeia for liver and gallbladder diseases, and is listed in gallbladder herb databases alongside artichoke and milk thistle.

• Quimioterapia (reducción de efectos secundarios)Tradicional

  P. kurroa is used in traditional Ayurvedic and Tibetan medicine for respiratory and lung disorders, including bronchitis and COPD-like presentations. The compound androsin is mechanistically active against PAF-induced lung inflammation. Clinical literature is limited to asthma-focused studies rather than lung health broadly.

• DefensividadTradicional

  P. kurroa is classically used in Ayurvedic and Tibetan medicine for upper respiratory conditions including colds, coughs, and sore throat. Traditional practitioners in Tibet, Nepal, and India widely recommend it for these complaints, and it is a listed traditional use in multiple ethnopharmacological reviews.

• Digestión (deficiente)Tradicional

  P. kurroa is categorized in Ayurveda as a powerful detoxifying and liver-stimulatory herb with laxative, choleretic, and hepatoprotective properties. The traditional concept of systemic cleansing (shodhana) is a core Ayurvedic use documented in classical texts and ethnopharmacological reviews.

Sistemas corporales que picrorhiza kurroa puede ayudar a apoyar.

• No hay sistemas corporales disponibles.